Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Iwona Bujak"'
Autor:
Iwona Dams, Anna Ostaszewska, Maria Puchalska, Justyna Chmiel, Piotr Cmoch, Iwona Bujak, Agata Białońska, Wojciech J. Szczepek
Publikováno v:
Molecules, Vol 20, Iss 12, Pp 21346-21363 (2015)
During the process development for multigram-scale synthesis of olmesartan medoxomil (OM), two principal regioisomeric process-related impurities were observed along with the final active pharmaceutical ingredient (API). The impurities were identifie
Externí odkaz:
https://doaj.org/article/597524469ce24822a97c25c3abeac4a0
Autor:
Olga Michalak, Marta Łaszcz, Kamil Jatczak, Anna Witkowska, Iwona Bujak, Aleksandra Groman, Marcin Cybulski
Publikováno v:
Molecules, Vol 20, Iss 8, Pp 13814-13829 (2015)
The preparation of stable amorphous pemetrexed disodium of pharmaceutical purity as well as the process optimization for the preparation of the hemipentahydrate form of pemetrexed disodium are described. Analytical methods for the polymorphic and che
Externí odkaz:
https://doaj.org/article/0c3e25990362450899db3321f5fbf416
Publikováno v:
Molecules, Vol 20, Iss 6, Pp 10004-10031 (2015)
A physicochemical characterization of the process-related impurities associated with the synthesis of pemetrexed disodium was performed. The possibility of pemetrexed impurities forming has been mentioned in literature, but no study on their structur
Externí odkaz:
https://doaj.org/article/284bc906aec946baa382f3166ca5d3bc
Autor:
Marcin Cybulski, Bartłomiej Żerek, Katarzyna Sidoryk, Piotr Rózga, Marta Świtalska, Iwona Bujak, Joanna Wietrzyk, Łukasz Kaczmarek
Publikováno v:
Medicinal Chemistry Research
An optimization of the guanidylation process by verifying the efficacy of common guanylation reagents in order to obtain the guanidine derivatives of indolo[2,3-b]quinoline has been performed. As a result, a high-yield procedure using N,N′-di-Boc-N
Autor:
Agata Białońska, Piotr Cmoch, Chmiel Justyna, Iwona Dams, Anna Ostaszewska, Maria Puchalska, Iwona Bujak, Wojciech Szczepek
Publikováno v:
Molecules
Volume 20
Issue 12
Pages 21346-21363
Molecules, Vol 20, Iss 12, Pp 21346-21363 (2015)
Molecules; Volume 20; Issue 12; Pages: 21346-21363
Volume 20
Issue 12
Pages 21346-21363
Molecules, Vol 20, Iss 12, Pp 21346-21363 (2015)
Molecules; Volume 20; Issue 12; Pages: 21346-21363
During the process development for multigram-scale synthesis of olmesartan medoxomil (OM), two principal regioisomeric process-related impurities were observed along with the final active pharmaceutical ingredient (API). The impurities were identifie
Autor:
Olga Michalak, Marta Łaszcz, Kinga Trzcińska, Anna Witkowska, Iwona Bujak, Piotr Cmoch, Mariusz Gruza
Pemetrexed is an antifolate antineoplastic agent that acts by inhibiting the formation of precursor purine and pyrimidine nucleotides. Pemetrexed prevents the formation of DNA and RNA, which are required for the growth and survival of both normal and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e40c2069657b824a047e0f517eb70181
https://doi.org/10.7287/peerj.preprints.1910v1
https://doi.org/10.7287/peerj.preprints.1910v1
Autor:
Aleksandra Groman, Marcin Cybulski, Kamil Jatczak, Iwona Bujak, Olga Michalak, Anna Witkowska, Marta Łaszcz
Publikováno v:
Molecules
Volume 20
Issue 8
Pages 13814-13829
Molecules, Vol 20, Iss 8, Pp 13814-13829 (2015)
Volume 20
Issue 8
Pages 13814-13829
Molecules, Vol 20, Iss 8, Pp 13814-13829 (2015)
The preparation of stable amorphous pemetrexed disodium of pharmaceutical purity as well as the process optimization for the preparation of the hemipentahydrate form of pemetrexed disodium are described. Analytical methods for the polymorphic and che